Thoratec Corporation

Skip to content

2015 Press Releases

Keyword Search

2015 | 2014 | 2013 | 2012 | 2011
DateTitle 
02/25/15Thoratec Announces Presentations At Investor Conferences For March 2015
PLEASANTON, Calif., Feb. 25, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in two upcoming investor conferences. On Wednesday, March 4, the company will participate in the Raymond James 36th Annual Institutional Investors Conference.  Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the compa... 
Printer Friendly Version
02/10/15Thoratec® Reports Fourth Quarter 2014 Results
- Revenue of $128.0 million for the fourth quarter of 2014 - GAAP net income per diluted share of $0.21, and non-GAAP net income per diluted share of $0.39 - Company establishes 2015 guidance for revenue of $450 million to $460 million and net income per diluted share of $0.60 to $0.70 on a GAAP basis and $1.10 to $1.20 on a non-GAAP basis PLEASANTON, Calif., Feb. 10, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support ... 
Printer Friendly Version
01/30/15Thoratec Presentation At Leerink Global Healthcare Conference To Be Webcast
PLEASANTON, Calif., Jan. 30, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Global Healthcare Conference on Thursday, February 12. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company beginning at 10:45 a.m., Eastern Standard Time (7:45 a.m., Pacific Standard Time).  ... 
Printer Friendly Version
01/28/15Thoratec Schedules Fourth Quarter Conference Call, Webcast
PLEASANTON, Calif., Jan. 28, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the fourth quarter of fiscal year 2014 on Tuesday, February 10. The company will hold a conference call to discuss its financial results and operating activities, open to all interested parties, at 1:30 p.m., Pacific Standard Time ... 
Printer Friendly Version
01/02/15Thoratec Presentation At J.P. Morgan Healthcare Conference To Be Webcast
PLEASANTON, Calif., Jan. 2, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14. D. Keith Grossman, President and Chief Executive Officer, will provide an update on the company beginning at 10:00 a.m., Pacific Standard Time (1:00 p.m., Eastern Standard Time). ... 
Printer Friendly Version